Medcaptain Medical Technology Co. Ltd. Class H

As of March 31, 2026, Medcaptain Medical Technology Co. Ltd. Class H has 479.22M shares outstanding.

As of March 31, 2026, Medcaptain Medical Technology Co. Ltd. Class H maintains a current ratio of 1.64, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 23.04, indicating elevated leverage, while an interest coverage ratio of 12.08 demonstrates strong ability to service its debt obligations.

Over the twelve months ended March 31, 2026, Medcaptain Medical Technology Co. Ltd. Class H recorded 6.66M in income tax expense. That works out to an effective tax rate of 175.86, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items.

These figures cover the twelve months ended March 31, 2026.

As of March 31, 2026, Medcaptain Medical Technology Co. Ltd. Class H holds 543.89M in cash and equivalents against 495.26M in total debt, resulting in a net debt position of 10.10M. Total book value stands at 2.15B, with working capital of 429.28M providing operational flexibility.

These figures cover the twelve months ended March 31, 2026. After subtracting -25.78M in capital expenditures, free cash flow totaled 17.45M - equivalent to 0.03 per share.

Over the twelve months ended March 31, 2026, Medcaptain Medical Technology Co. Ltd. Class H posted a gross margin of 54.27, reflecting its pricing power and cost economics. The operating margin of 2.58 and net profit margin of -0.73 provide insight into operational efficiency.